Sodium Hydroxide → 1,1-Dimethylethyl 4-[5-(hydroxymethyl)-1,2,4-oxadiazol-3-yl]piperazine-1-carboxylate
Reaction equation
C([O:4][CH2:5][C:6]1[O:10][N:9]=[C:8]([N:11]2[CH2:16][CH2:15][N:14]([C:17]([O:19][C:20]([CH3:23])([CH3:22])[CH3:21])=[O:18])[CH2:13][CH2:12]2)[N:7]=1)(=O)C.[OH-].[Na+]>CO>[OH:4][CH2:5][C:6]1[O:10][N:9]=[C:8]([N:11]2[CH2:12][CH2:13][N:14]([C:17]([O:19][C:20]([CH3:23])([CH3:22])[CH3:21])=[O:18])[CH2:15][CH2:16]2)[N:7]=1Participants
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
1,1-Dimethylethyl 4-{5-[(acetoxy)methyl]-1,2,4-oxadiazol-3-yl}piperazine-1-carboxylate (13.57 g, 41.6 mmol) was dissolved in methanol (100 mL) followed by addition of aqueous sodium hydroxide (4M, 10.4 mL) and the mixture was stirred for 30 minutes at room temperature. The reaction mixture was then concentrated in vacuo and the residue partitioned with ethyl acetate and 0.1M aqueous hydrochloric acid. The organic layer was then washed with saturated aqueous sodium chloride then dried over anhydrous magnesium sulfate. Filtration and concentration afforded 1,1-dimethylethyl 4-[5-(hydroxymethyl)-1,2,4-oxadiazol-3-yl]piperazine-1-carboxylate (10.51 g, 89% yield) as a colorless crystalline solid. 1H-NMR (400 MHz, CDCl3): 4.75 (s, 2H), 3.53-3.50 (m, 4H), 3.44-3.42 (m, 4H), 3.20 (br s, 1H), 1.48 (s, 9H).
Workup
- concentrationThe reaction mixture was then concentrated in vacuo
- customthe residue partitioned with ethyl acetate and 0.1M aqueous hydrochloric acid
- washThe organic layer was then washed with saturated aqueous sodium chloride
- dry with materialthen dried over anhydrous magnesium sulfate
- filtrationFiltration and concentration
Sources & evidence
- ORD record
- ord-6776caf8f3d445be85cc92a634c58343
- Source dataset
- uspto-grants-2016_06
- Patent number
- US09359332B2
Reaction notes
Loading…